| Date Filed | Type | Description |
| 02/16/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019133 |
| 07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019131 |
| 07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019129 |
| 07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019128 |
| 06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
| 06/30/2009 |
S-8 POS
| Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
| 06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
| 06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
| 06/30/2009 |
S-8 POS
| Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/30/2009 |
S-8 POS
| Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/30/2009 |
15-12B
| Form 15-12B -- Securities registration termination [Section 12(b)] |
| 06/02/2009 |
8-K
| Quarterly results |
| 06/01/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2009 |
4
| Hamilton J Michael (Chief Medical Officer) has filed a Form 4 on AVALON PHARMACEUTICALS INC |
| 06/01/2009 |
4
| Carter Kenneth C (President and CEO) has filed a Form 4 on AVALON PHARMACEUTICALS INC |
| 05/28/2009 |
25-NSE
| Form 25-NSE -- |
| 05/13/2009 |
10-Q
| Quarterly Report for the period ended March 31, 2009 |
| 05/06/2009 |
8-K
| Form 8-K -- Current report |
| 05/06/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
| 04/28/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
| 04/02/2009 |
8-K
| Form 8-K -- Current report |
| 04/02/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
| 03/31/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/17/2009 |
8-K
| Form 8-K -- Current report |
| 03/10/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/17/2009 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 4.6% stake in AVALON PHARMACEUTICALS, INC. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2009 |
SC 13D/A
| OBP Management III L.P. has filed a Schedule 13D for Avalon Pharmaceuticals, Inc. |
| 01/30/2009 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 6.1% stake in Avalon Pharmaceuticals Inc. |
| 01/21/2009 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8.2% stake in Avalon Pharmaceuticals, Inc. |
| 01/14/2009 |
8-K
| Form 8-K -- Current report |
|